2023³â ´ëÇÑ Áٱ⼼Æ÷¡¤Á¶Á÷Àç»ý ÇÐȸ Ãß°èÇмú´ëȸ : 2023-12-03
±³À°ÀÏÀÚ : 2023-12-03
±³À°Àå¼Ò : Áß¾Ó´ëÇб³º´¿ø ¼ÛºÀȦ
±³À°ÁÖÁ¦ : 2023³â ´ëÇÑ Áٱ⼼Æ÷¡¤Á¶Á÷Àç»ý ÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÁٱ⼼Æ÷Á¶Á÷Àç»ýÇÐȸ
´ã´çÀÚ : ±èÇöÁ¤
¿¬¶ôó : 02-0000-0000
À̸ÞÀÏ : str1orkr@gmail.com
±³À°Á¾·ù : Á¤Çü¿Ü°ú, ¼ºÇü¿Ü°ú, ÇǺΰú, ¸¶ÃëÅëÁõÀÇÇаú, ÀçÈ°ÀÇÇаú
Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 60,000¿ø
ºñ°í "<»çÀüµî·Ï>
Á¤È¸¿ø: 30,000¿ø / Àü°øÀÇ: 40,000¿ø / Àü¹®ÀÇ: 50,000¿ø
<ÇöÀåµî·Ï>
Á¤È¸¿ø: 40,000¿ø / Àü°øÀÇ: 50,000¿ø / Àü¹®ÀÇ: 60,000¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 09:00~09:40 ÃÊÀÓ°è Å»¼¼Æ÷ °øÁ¤À» ÀÌ¿ëÇÑ µ¿Á¾ÀÌ½Ä Àç·áÀÇ ¾ÈÀü¼º, À¯È¿¼º °íÂû ÇãÂù¿µ(¼¿ïÀÇ´ë ºÐ´ç¼¿ï´ëº´¿ø ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 09:40~10:20 ÷´Ü¹ÙÀÌ¿ÀÀǾàÇ°°ú ÷´ÜÀç»ýÀÇ·á Àӻ󿬱¸ ±è±âÁÖ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø ¼¼Æ÷Ä¡·á¼¾ÅÍ)
Åä·Ð 12¿ù 03ÀÏ ¼ÛºÀȦ 10:20~10:30 Discussion ()
ÈÞ½Ä 12¿ù 03ÀÏ 10:30~10:50 Coffee Break ()
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 10:50~11:20 Áٱ⼼Æ÷ Åõ¿©¿ë·®ÀÇ Á¤ÀÇ; °³¼ö¿Í ¹«°Ô ÀÌÈñ¿µ(¹Ù·ÎÀϼºÇü¿Ü°ú)
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 11:20~11:40 ȯÀÚ¸ÂÃãÇü ½Å°æÁٱ⼼Æ÷ÀÇ Ã´Ãß¼Õ»ó Ä¡·áÁ¦·Î¼ÀÇ ÀüÀÓ»ó Æò°¡ À¯½Â±Ç(°í·Á´ë »ý¸í°úÇаú)
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 11:40~12:00 À¯µµ¸¸´ÉÁٱ⼼Æ÷¸¦ ÀÌ¿ëÇÑ ¿¬°ñÀç»ýÄ¡·á ÁÖÁöÇö(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø ·ù¸¶Æ¼½º³»°ú)
Åä·Ð 12¿ù 03ÀÏ ¼ÛºÀȦ 12:00~12:10 Discussion ()
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 12:10~12:30 ±¹¼Ò ¼Ò¿° ÁøÅë¸ñÀûÀÇ Ã´Ã߰渷 ¹× °üÀý±ÙÀ°ÁÖ»çÀÇ ÃֽŠÁö°ß ±èÇü±Ô(¿¬¼¼Á¦ÀÏÁ¤Çü¿Ü°ú)
Åä·Ð 12¿ù 03ÀÏ ¼ÛºÀȦ 12:30~12:40 Discussion ()
½Ä»ç 12¿ù 03ÀÏ 12:40~13:40 Lunch ()
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 13:40~14:00 Pathophysiological characteristics of Lymphangiogenesis ¼¹Ì¸®(Â÷ÀÇ´ë ºÐ´çÂ÷º´¿ø ÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 14:00~14:20 Lymphedema Surgery and VEGF Delivery ¸íÀ¯Áø(¼¿ïÀÇ´ë ºÐ´ç¼¿ï´ëº´¿ø ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 14:20~14:40 Çü»ó±â¾ïÃʼÒÇü Lymph Vessel Graft ¼ºÇÐÁØ(¿¬¼¼ÀÇ´ë ÀÇÇаøÇб³½Ç)
Åä·Ð 12¿ù 03ÀÏ ¼ÛºÀȦ 14:40~14:50 Discussion ()
ÈÞ½Ä 12¿ù 03ÀÏ 14:50~15:10 Coffee Break ()
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 15:10~15:30 Potential advantages of engineered cartilage: a clinical ¹Úµµ¿µ(¾ÆÁִ뺴¿ø ¼ºÇü¿Ü°ú)
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 15:30~15:50 Application od BMAC in Vitro, Preclinical and Clinical Study ±è»óÁØ(¼¿ïÁØÀçÈ°ÀÇÇаú)
±³À°½Ã°£ 12¿ù 03ÀÏ ¼ÛºÀȦ 15:50~16:10 Á¶Á÷Àç»ý Ä¡·áÀÇ ÀûÀÀÁõ È®Àå Ä¡·á¿¡ ´ëÇÑ °íÂû ÀÌ»óÈÆ(SNU¼¿ïº´¿ø)
Åä·Ð 12¿ù 03ÀÏ ¼ÛºÀȦ 16:10~16:20 Discussion ()